Physician profile
Rebecca Anne Deal
NPI 1134565013
$18,195.67
in general payments reported to CMS, 2019-2025
9 companies · $3,065 in 2025
The $3,065 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $94.48 · 2021: $12K · 2022: $593 · 2023: $1,954 · 2024: $416 · 2025: $3,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $1,400 · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $1,400.23 |
| Food and Beverage | $534.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,779.30 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $795.41 | 2023 | Advantagerib |
| Kerecis Limited | $285.17 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Becton, Dickinson and Company | $216.23 | 2023-2024 | Phasix Mesh |
| Conmed Corporation | $33.33 | 2022 | |
| Hologic Sales and Service, LLC | $31.26 | 2024 | Trunode, Localizer, Biozorb |
| Acera Surgical, INC. | $21.36 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $19.70 | 2021 | |
| Aroa Biosurgery Incorporated | $13.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Deal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.